Acasti Pharma Correlations

ACST
 Stock
  

USD 0.60  0.01  1.64%   

The correlation of Acasti Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acasti Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acasti Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Please continue to Trending Equities.
  
The ability to find closely correlated positions to Acasti Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acasti Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acasti Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acasti Pharma to buy it.

Moving together with Acasti Pharma

+0.78PGProcter GamblePairCorr
+0.73INTCIntel CorpPairCorr

Moving against Acasti Pharma

-0.53REGNRegeneron PharmaceuticalsPairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AF
CRMMSFT
MRKT
FUBER
AUBER
XOMF
  
High negative correlations   

Acasti Pharma Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Acasti Stock performing well and Acasti Pharma company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Acasti Pharma's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 1.64  0.19  0.07  0.18  2.79  0.08 (1.56)  4.00 (2.55)  15.22 
MSFT 1.37 (0.02)  0.00 (0.09)  0.00 (0.0255)  0.00  2.78 (3.17)  12.18 
UBER 2.87  0.44  0.13  0.27  2.91  0.11 (3.12)  5.60 (4.70)  25.11 
F 2.22  0.23  0.05  0.05  3.06  0.06 (2.39)  5.18 (3.74)  18.47 
T 1.00 (0.36)  0.00 (0.62)  0.00 (0.23)  0.00  1.65 (2.33)  9.46 
A 1.61  0.15  0.07  0.05  1.88  0.06 (1.78)  2.87 (3.13)  11.70 
CRM 2.08 (0.10)  0.00 (0.14)  0.00 (0.06)  0.00  3.94 (4.55)  12.87 
JPM 1.31  0.00  0.00 (0.08)  0.00 (0.0114)  0.00  2.61 (2.88)  8.06 
MRK 0.93 (0.07)  0.00 (0.23)  0.00 (0.022)  0.00  1.64 (2.13)  4.57 
XOM 1.76  0.04  0.03 (0.01)  2.18  0.0307 (1.81)  3.19 (3.69)  9.95 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Acasti Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Commodity Channel Index Now

   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Acasti Pharma Corporate Directors

Acasti Pharma corporate directors refer to members of an Acasti Pharma board of directors. The board of directors generally takes responsibility for the Acasti Pharma's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Acasti Pharma's board members must vote for the resolution. The Acasti Pharma board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Richard Schottenfeld - DirectorProfile
Valier Boivin - Independent DirectorProfile
Jean Belanger - Secretary, Director- Corporate AffairsProfile
JeanDaniel Belanger - Secretary, Director- Corporate AffairsProfile

Invested in Acasti Pharma?

The danger of trading Acasti Pharma is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Acasti Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Acasti Pharma. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Acasti Pharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for analysis

When running Acasti Pharma price analysis, check to measure Acasti Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acasti Pharma is operating at the current time. Most of Acasti Pharma's value examination focuses on studying past and present price action to predict the probability of Acasti Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acasti Pharma's price. Additionally, you may evaluate how the addition of Acasti Pharma to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Acasti Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acasti Pharma. If investors know Acasti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acasti Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Acasti Pharma is measured differently than its book value, which is the value of Acasti that is recorded on the company's balance sheet. Investors also form their own opinion of Acasti Pharma's value that differs from its market value or its book value, called intrinsic value, which is Acasti Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acasti Pharma's market value can be influenced by many factors that don't directly affect Acasti Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acasti Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Acasti Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acasti Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.